NCT05343624: A reported trial by University Hospitals Cleveland Medical Center
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05343624 |
|---|---|
| Title | Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 18, 2020 |
| Completion date | Dec. 1, 2021 |
| Required reporting date | Dec. 1, 2022, midnight |
| Actual reporting date | Nov. 22, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |